[Risks factors for death among COVID-19 patients combined with hypertension, coronary heart disease or diabetes]

H Yang1, L C Yang2, R T Zhang2

  • 1Department of Cardiac Surgery, Peking University Third Hospital, Beijing 100191, China.

Insights

Older age, low oxygen saturation, and elevated interleukin-10 levels are key predictors of mortality in COVID-19 patients with pre-existing conditions like hypertension or diabetes. These factors significantly increase the risk of death in this vulnerable population.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • The precise mechanisms driving myocardial injury in COVID-19 remain unclear.
  • Evidence linking COVID-19 to adverse outcomes in patients with comorbidities is limited.

Purpose of the Study:

  • To identify risk factors for mortality in COVID-19 patients who also have hypertension, coronary heart disease, or diabetes.

Main Methods:

  • A retrospective, observational study was conducted at a single center in Wuhan, China.
  • Clinical and laboratory data from 94 COVID-19 patients with hypertension, coronary heart disease, or diabetes were analyzed.
  • Logistic regression was used to determine independent risk factors for death.

Main Results:

  • The study identified older age, low oxygen saturation, low lymphocyte count, myocardial injury markers (CK-MB, hs-cTnI, NT-proBNP), and elevated inflammatory cytokines (IL-2R, IL-6, IL-10) as associated with mortality.
  • Multivariate analysis revealed that older age (OR=1.11), low non-oxygen saturation (OR=0.85), and elevated IL-10 (OR=101.93) were independent predictors of death.

Conclusions:

  • Older age, low oxygen saturation, and elevated interleukin-10 are significant independent risk factors for death in COVID-19 patients with cardiovascular comorbidities.
  • These findings highlight the importance of monitoring these parameters in high-risk COVID-19 patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
773
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
234
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
522
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
606
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
358
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
6.2K